about
Recent progress in the development of polysaccharide conjugates of docetaxel and paclitaxelPhotoacoustic Imaging of Cancer Treatment Response: Early Detection of Therapeutic Effect from Thermosensitive LiposomesPhotoacoustic signal characterization of cancer treatment response: Correlation with changes in tumor oxygenation.Intraannular Savige-Fontana reaction: one-step conversion of one class of monocyclic peptides into another class of bicyclic peptides.Tryptathionine bridges in peptide synthesis.Synthesis of a Cytotoxic Amanitin for Biorthogonal Conjugation.Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors.Correction: Photoacoustic Imaging of Cancer Treatment Response: Early Detection of Therapeutic Effect from Thermosensitive Liposomes.A new dark quencher for use in genetic analysis.Synthesis and evaluation of a new non-fluorescent quencher in fluorogenic oligonucleotide probes for real-time PCR.Synthesis, characterisation, and in vitro evaluation of Pro2-Ile3-S-deoxo-amaninamide and Pro2-D-allo-Ile3-S-deoxo-amaninamide: implications for structure-activity relationships in amanitin conformation and toxicity.High yielding synthesis of 3a-hydroxypyrrolo[2,3-b]indoline dipeptide methyl esters: synthons for expedient introduction of the hydroxypyrroloindoline moiety into larger peptide-based natural products and for the creation of tryptathionine bridges.Synthesis of a Gemcitabine Prodrug for Remote Loading into Liposomes and Improved Therapeutic Effect.Covalent Schiff base catalysis and turnover by a DNAzyme: a M2+ -independent AP-endonuclease mimicStereoselective synthesis of brevianamide EA thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacyA Study of Liposomal Formulations to Improve the Delivery of Aquated Cisplatin to a Multidrug Resistant Tumor
P50
Q27010654-707795C9-6916-431A-92EA-758D6C2DC06DQ28553001-B2E42D91-52ED-44A8-B447-9D87D44B82F5Q30359234-76431d84-45a8-b1a0-af91-ee7e4ddb6120Q33320290-1A90426F-E992-4B16-8D41-279BDA525A96Q36878445-0D5E3C59-F0E0-4D88-941F-1774E781BF29Q38867593-131F4718-8EE7-4B03-9AA8-2576B60CE329Q39072889-C9247BF9-04F2-492B-8F6E-F7B58D201305Q42317141-937038c7-406b-82bb-5784-8860d23db85cQ44439202-916377C0-234F-4429-A216-660044BB09F3Q46585363-B5E2F1B4-8B5D-4E27-A536-86A6892CE49DQ46728346-D32F1EF3-A97E-49BC-A22D-78E5587528A6Q46739368-78542B10-A7FF-4547-84B5-4E48F0B4C18EQ50901890-66028BB0-6D58-4586-B569-2D2FF8539CC1Q79844180-1F31801A-C912-4059-9300-AD12B201B8B9Q82725869-DB328638-B68D-491A-A7D5-A9EA84FB8958Q83892109-F9284A6A-F9E8-4A63-9E62-441AC9F77E21Q87289439-7CA62C52-E187-4135-8FBB-9BC5365A575E
P50
description
researcher, Ontario Institute for Cancer Research
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jonathan P May
@ast
Jonathan P May
@es
Jonathan P May
@nl
Jonathan P May
@sl
Jonathan P. May
@da
Jonathan P. May
@de
Jonathan P. May
@en
Jonathan P. May
@fo
Jonathan P. May
@fr
Jonathan P. May
@is
type
label
Jonathan P May
@ast
Jonathan P May
@es
Jonathan P May
@nl
Jonathan P May
@sl
Jonathan P. May
@da
Jonathan P. May
@de
Jonathan P. May
@en
Jonathan P. May
@fo
Jonathan P. May
@fr
Jonathan P. May
@is
altLabel
J. P. May
@en
JP May
@en
Jonathan May
@en
Jonathan P May
@en
prefLabel
Jonathan P May
@ast
Jonathan P May
@es
Jonathan P May
@nl
Jonathan P May
@sl
Jonathan P. May
@da
Jonathan P. May
@de
Jonathan P. May
@en
Jonathan P. May
@fo
Jonathan P. May
@fr
Jonathan P. May
@is
P1053
P1053
C-1944-2015
M-3742-2013
T-4546-2017
P106
P21
P31
P3829
P496
0000-0003-1651-130X